{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T19:35:30Z","timestamp":1777318530305,"version":"3.51.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s11882-021-01010-1","type":"journal-article","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T10:08:49Z","timestamp":1620641329000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Hereditary Alpha-Tryptasemia: a Commonly Inherited Modifier of Anaphylaxis"],"prefix":"10.1007","volume":"21","author":[{"given":"Richard","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan J.","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,10]]},"reference":[{"issue":"6","key":"1010_CR1","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.aller.2014.05.002","volume":"42","author":"C Fellinger","year":"2014","unstructured":"Fellinger C, Hemmer W, Wohrl S, Sesztak-Greinecker G, Jarisch R, Wantke F. Clinical characteristics and risk profile of patients with elevated baseline serum tryptase. Allergol Immunopathol (Madr). 2014;42(6):544\u201352. https:\/\/doi.org\/10.1016\/j.aller.2014.05.002.","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"2","key":"1010_CR2","first-page":"65","volume":"17","author":"I Kucharewicz","year":"2007","unstructured":"Kucharewicz I, Bodzenta-Lukaszyk A, Szymanski W, Mroczko B, Szmitkowski M. Basal serum tryptase level correlates with severity of hymenoptera sting and age. J Investig Allergol Clin Immunol. 2007;17(2):65\u20139.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"2","key":"1010_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/all.12317","volume":"69","author":"UM Sahiner","year":"2014","unstructured":"Sahiner UM, Yavuz ST, Buyuktiryaki B, Cavkaytar O, Yilmaz EA, Tuncer A, et al. Serum basal tryptase may be a good marker for predicting the risk of anaphylaxis in children with food allergy. Allergy. 2014;69(2):265\u20138. https:\/\/doi.org\/10.1111\/all.12317.","journal-title":"Allergy."},{"issue":"3","key":"1010_CR4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000497235","volume":"179","author":"V Aniceto","year":"2019","unstructured":"Aniceto V, Dias MM, Melo JML, Trevisan-Neto O, Aragon DC, Maia LSM, et al. Serum baseline tryptase level as a marker for the severity of anaphylaxis. Int Arch Allergy Immunol. 2019;179(3):201\u20138. https:\/\/doi.org\/10.1159\/000497235.","journal-title":"Int Arch Allergy Immunol"},{"issue":"9","key":"1010_CR5","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1046\/j.1365-2222.2003.01755.x","volume":"33","author":"G Haeberli","year":"2003","unstructured":"Haeberli G, Bronnimann M, Hunziker T, Muller U. Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy. Clin Exp Allergy. 2003;33(9):1216\u201320. https:\/\/doi.org\/10.1046\/j.1365-2222.2003.01755.x.","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"1010_CR6","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jaci.2009.08.027","volume":"124","author":"F Rueff","year":"2009","unstructured":"Rueff F, Przybilla B, Bilo MB, Muller U, Scheipl F, Aberer W, et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol. 2009;124(5):1047\u201354. https:\/\/doi.org\/10.1016\/j.jaci.2009.08.027.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1010_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/ajd.12146","volume":"56","author":"E Aberer","year":"2015","unstructured":"Aberer E, Savic S, Bretterklieber A, Reiter H, Berghold A, Aberer W. Disease spectrum in patients with elevated serum tryptase levels. Aust J Dermatol. 2015;56(1):7\u201313. https:\/\/doi.org\/10.1111\/ajd.12146.","journal-title":"Aust J Dermatol"},{"issue":"2","key":"1010_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1398-9995.2007.01569.x","volume":"63","author":"K Brockow","year":"2008","unstructured":"Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy. 2008;63(2):226\u201332. https:\/\/doi.org\/10.1111\/j.1398-9995.2007.01569.x.","journal-title":"Allergy."},{"issue":"1","key":"1010_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/cea.12225","volume":"44","author":"T Gulen","year":"2014","unstructured":"Gulen T, Hagglund H, Dahlen B, Nilsson G. High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience. Clin Exp Allergy. 2014;44(1):121\u20139. https:\/\/doi.org\/10.1111\/cea.12225.","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"1010_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1056\/NEJMra1409760","volume":"373","author":"TC Theoharides","year":"2015","unstructured":"Theoharides TC, Valent P, Akin C. Mast cells, mastocytosis, and related disorders. N Engl J Med. 2015;373(2):163\u201372. https:\/\/doi.org\/10.1056\/NEJMra1409760.","journal-title":"N Engl J Med"},{"issue":"2","key":"1010_CR11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1067\/mai.2002.121454","volume":"109","author":"B Foster","year":"2002","unstructured":"Foster B, Schwartz LB, Devouassoux G, Metcalfe DD, Prussin C. Characterization of mast-cell tryptase-expressing peripheral blood cells as basophils. J Allergy Clin Immunol. 2002;109(2):287\u201393. https:\/\/doi.org\/10.1067\/mai.2002.121454.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"1010_CR12","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.4049\/jimmunol.126.4.1290","volume":"126","author":"LB Schwartz","year":"1981","unstructured":"Schwartz LB, Lewis RA, Seldin D, Austen KF. Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells. J Immunol. 1981;126(4):1290\u20134.","journal-title":"J Immunol"},{"issue":"6","key":"1010_CR13","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1172\/JCI118337","volume":"96","author":"LB Schwartz","year":"1995","unstructured":"Schwartz LB, Sakai K, Bradford TR, Ren S, Zweiman B, Worobec AS, et al. The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest. 1995;96(6):2702\u201310. https:\/\/doi.org\/10.1172\/JCI118337.","journal-title":"J Clin Invest"},{"issue":"11","key":"1010_CR14","doi-asserted-by":"publisher","first-page":"5667","DOI":"10.4049\/jimmunol.170.11.5667","volume":"170","author":"LB Schwartz","year":"2003","unstructured":"Schwartz LB, Min HK, Ren S, Xia HZ, Hu J, Zhao W, et al. Tryptase precursors are preferentially and spontaneously released, whereas mature tryptase is retained by HMC-1 cells, Mono-Mac-6 cells, and human skin-derived mast cells. J Immunol. 2003;170(11):5667\u201373. https:\/\/doi.org\/10.4049\/jimmunol.170.11.5667.","journal-title":"J Immunol"},{"issue":"6","key":"1010_CR15","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/s0091-6749(99)70184-3","volume":"103","author":"S Kanthawatana","year":"1999","unstructured":"Kanthawatana S, Carias K, Arnaout R, Hu J, Irani AM, Schwartz LB. The potential clinical utility of serum alpha-protryptase levels. J Allergy Clin Immunol. 1999;103(6):1092\u20139. https:\/\/doi.org\/10.1016\/s0091-6749(99)70184-3.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1010_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.clim.2007.02.007","volume":"123","author":"C Akin","year":"2007","unstructured":"Akin C, Soto D, Brittain E, Chhabra A, Schwartz LB, Caughey GH, et al. Tryptase haplotype in mastocytosis: relationship to disease variant and diagnostic utility of total tryptase levels. Clin Immunol. 2007;123(3):268\u201371. https:\/\/doi.org\/10.1016\/j.clim.2007.02.007.","journal-title":"Clin Immunol"},{"issue":"3","key":"1010_CR17","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.iac.2006.05.010","volume":"26","author":"LB Schwartz","year":"2006","unstructured":"Schwartz LB. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin N Am. 2006;26(3):451\u201363. https:\/\/doi.org\/10.1016\/j.iac.2006.05.010.","journal-title":"Immunol Allergy Clin N Am"},{"issue":"5","key":"1010_CR18","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1515\/CCLM.2010.124","volume":"48","author":"A Gonzalez-Quintela","year":"2010","unstructured":"Gonzalez-Quintela A, Vizcaino L, Gude F, Rey J, Meijide L, Fernandez-Merino C, et al. Factors influencing serum total tryptase concentrations in a general adult population. Clin Chem Lab Med. 2010;48(5):701\u20136. https:\/\/doi.org\/10.1515\/CCLM.2010.124.","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"1010_CR19","first-page":"282","volume":"23","author":"AE Sirvent","year":"2010","unstructured":"Sirvent AE, Gonzalez C, Enriquez R, Fernandez J, Millan I, Barber X, et al. Serum tryptase levels and markers of renal dysfunction in a population with chronic kidney disease. J Nephrol. 2010;23(3):282\u201390.","journal-title":"J Nephrol"},{"issue":"11","key":"1010_CR20","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","volume":"129","author":"P Valent","year":"2017","unstructured":"Valent P, Akin C, Metcalfe DD. Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts. Blood. 2017;129(11):1420\u20137. https:\/\/doi.org\/10.1182\/blood-2016-09-731893.","journal-title":"Blood."},{"issue":"5","key":"1010_CR21","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1586\/17474086.2014.955008","volume":"7","author":"P Valent","year":"2014","unstructured":"Valent P, Sperr WR, Sotlar K, Reiter A, Akin C, Gotlib J, et al. The serum tryptase test: an emerging robust biomarker in clinical hematology. Expert Rev Hematol. 2014;7(5):683\u201390. https:\/\/doi.org\/10.1586\/17474086.2014.955008.","journal-title":"Expert Rev Hematol"},{"issue":"5","key":"1010_CR22","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.jaci.2013.11.039","volume":"133","author":"JJ Lyons","year":"2014","unstructured":"Lyons JJ, Sun G, Stone KD, Nelson C, Wisch L, O\u2019Brien M, et al. Mendelian inheritance of elevated serum tryptase associated with atopy and connective tissue abnormalities. J Allergy Clin Immunol. 2014;133(5):1471\u20134. https:\/\/doi.org\/10.1016\/j.jaci.2013.11.039.","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"1010_CR23","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/ng.3696","volume":"48","author":"JJ Lyons","year":"2016","unstructured":"Lyons JJ, Yu X, Hughes JD, Le QT, Jamil A, Bai Y, et al. Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number. Nat Genet. 2016;48(12):1564\u20139. https:\/\/doi.org\/10.1038\/ng.3696.","journal-title":"Nat Genet"},{"issue":"6","key":"1010_CR24","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.jaci.2014.06.007","volume":"134","author":"V Sabato","year":"2014","unstructured":"Sabato V, Van De Vijver E, Hagendorens M, Vrelust I, Reyniers E, Fransen E, et al. Familial hypertryptasemia with associated mast cell activation syndrome. J Allergy Clin Immunol. 2014;134(6):1448\u201350 e3. https:\/\/doi.org\/10.1016\/j.jaci.2014.06.007.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"1010_CR25","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/gim.2017.136","volume":"20","author":"JJ Lyons","year":"2018","unstructured":"Lyons JJ, Stotz SC, Chovanec J, Liu Y, Lewis KL, Nelson C, et al. A common haplotype containing functional CACNA1H variants is frequently coinherited with increased TPSAB1 copy number. Genet Med. 2018;20(5):503\u201312. https:\/\/doi.org\/10.1038\/gim.2017.136.","journal-title":"Genet Med"},{"issue":"3","key":"1010_CR26","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.iac.2018.04.003","volume":"38","author":"JJ Lyons","year":"2018","unstructured":"Lyons JJ. Hereditary alpha tryptasemia: genotyping and associated clinical features. Immunol Allergy Clin N Am. 2018;38(3):483\u201395. https:\/\/doi.org\/10.1016\/j.iac.2018.04.003.","journal-title":"Immunol Allergy Clin N Am"},{"issue":"5","key":"1010_CR27","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.jaip.2016.11.037","volume":"5","author":"JC Doong","year":"2017","unstructured":"Doong JC, Chichester K, Oliver ET, Schwartz LB, Saini SS. Chronic idiopathic urticaria: systemic complaints and their relationship with disease and immune measures. J Allergy Clin Immunol Pract. 2017;5(5):1314\u20138. https:\/\/doi.org\/10.1016\/j.jaip.2016.11.037.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1010_CR28","doi-asserted-by":"publisher","unstructured":"Giannetti MP, Akin C, Hufdhi R, Hamilton MJ, Weller E, van Anrooij B, et al. Patients with mast cell activation symptoms and elevated baseline serum tryptase have unique bone marrow morphology. J Allergy Clin Immunol. 2020. https:\/\/doi.org\/10.1016\/j.jaci.2020.11.017First study to demonstrate unique bone marrow mast cell findings associated with H\u03b1T among MCAS patients.","DOI":"10.1016\/j.jaci.2020.11.017"},{"issue":"2","key":"1010_CR29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","volume":"117","author":"HA Sampson","year":"2006","unstructured":"Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;117(2):391\u20137. https:\/\/doi.org\/10.1016\/j.jaci.2005.12.1303.","journal-title":"J Allergy Clin Immunol"},{"key":"1010_CR30","doi-asserted-by":"publisher","unstructured":"Lyons JJ, Chovanec J, O\u2019Connell MP, Liu Y, Selb J, Zanotti R, et al. Heritable risk for severe anaphylaxis associated with increased alpha-tryptase-encoding germline copy number at TPSAB1. J Allergy Clin Immunol. 2020. https:\/\/doi.org\/10.1016\/j.jaci.2020.06.035First study to demonstrate H\u03b1T as a modifier of anaphylaxis in systemic mastocytosis (SM) and venom allergy, and to demonstrate increased prevalence among patients with SM as idiopathic anaphylaxis.","DOI":"10.1016\/j.jaci.2020.06.035"},{"issue":"3","key":"1010_CR31","doi-asserted-by":"publisher","first-page":"180","DOI":"10.2500\/aap.2019.40.4211","volume":"40","author":"PG Cetinkaya","year":"2019","unstructured":"Cetinkaya PG, Buyuktiryaki B, Soyer O, Sahiner UM, Sekerel BE. Factors predicting anaphylaxis in children with tree nut allergies. Allergy Asthma Proc. 2019;40(3):180\u20136. https:\/\/doi.org\/10.2500\/aap.2019.40.4211.","journal-title":"Allergy Asthma Proc"},{"issue":"4","key":"1010_CR32","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4168\/aair.2014.6.4.304","volume":"6","author":"P Wongkaewpothong","year":"2014","unstructured":"Wongkaewpothong P, Pacharn P, Sripramong C, Boonchoo S, Piboonpocanun S, Visitsunthorn N, et al. The utility of serum tryptase in the diagnosis of food-induced anaphylaxis. Allergy, Asthma Immunol Res. 2014;6(4):304\u20139. https:\/\/doi.org\/10.4168\/aair.2014.6.4.304.","journal-title":"Allergy, Asthma Immunol Res"},{"issue":"1","key":"1010_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12948-015-0017-9","volume":"13","author":"C Mirone","year":"2015","unstructured":"Mirone C, Preziosi D, Mascheri A, Micarelli G, Farioli L, Balossi LG, et al. Identification of risk factors of severe hypersensitivity reactions in general anaesthesia. Clin Mol Allergy. 2015;13(1):11. https:\/\/doi.org\/10.1186\/s12948-015-0017-9.","journal-title":"Clin Mol Allergy"},{"issue":"7","key":"1010_CR34","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1182\/blood-2006-06-028100","volume":"110","author":"C Akin","year":"2007","unstructured":"Akin C, Scott LM, Kocabas CN, Kushnir-Sukhov N, Brittain E, Noel P, et al. Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with \u201cidiopathic\u201d anaphylaxis. Blood. 2007;110(7):2331\u20133. https:\/\/doi.org\/10.1182\/blood-2006-06-028100.","journal-title":"Blood."},{"issue":"1","key":"1010_CR35","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jaci.2017.05.036","volume":"141","author":"MC Carter","year":"2018","unstructured":"Carter MC, Desai A, Komarow HD, Bai Y, Clayton ST, Clark AS, et al. A distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis. J Allergy Clin Immunol. 2018;141(1):180\u20138 e3. https:\/\/doi.org\/10.1016\/j.jaci.2017.05.036.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1010_CR36","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.iac.2014.01.003","volume":"34","author":"K Brockow","year":"2014","unstructured":"Brockow K. Epidemiology, prognosis, and risk factors in mastocytosis. Immunol Allergy Clin N Am. 2014;34(2):283\u201395. https:\/\/doi.org\/10.1016\/j.iac.2014.01.003.","journal-title":"Immunol Allergy Clin N Am"},{"issue":"4","key":"1010_CR37","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10875-018-0506-y","volume":"38","author":"V Sabato","year":"2018","unstructured":"Sabato V, Chovanec J, Faber M, Milner JD, Ebo D, Lyons JJ. First identification of an inherited TPSAB1 quintuplication in a patient with clonal mast cell disease. J Clin Immunol. 2018;38(4):457\u20139. https:\/\/doi.org\/10.1007\/s10875-018-0506-y.","journal-title":"J Clin Immunol"},{"key":"1010_CR38","doi-asserted-by":"publisher","unstructured":"Greiner G, Sprinzl B, Gorska A, Ratzinger F, Gurbisz M, Witzeneder N, et al. Hereditary alpha tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis. Blood. 2020. https:\/\/doi.org\/10.1182\/blood.2020006157Critical validation study demonstrating H\u03b1T as a modifier of systemic mastocytosis (SM), and the first study to demonstrate a gene dosage effect on mast cell mediator symptoms in SM patients using a validated clinical scoring system.","DOI":"10.1182\/blood.2020006157"},{"issue":"7","key":"1010_CR39","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/nri3690","volume":"14","author":"S Wernersson","year":"2014","unstructured":"Wernersson S, Pejler G. Mast cell secretory granules: armed for battle. Nat Rev Immunol. 2014;14(7):478\u201394. https:\/\/doi.org\/10.1038\/nri3690.","journal-title":"Nat Rev Immunol"},{"key":"1010_CR40","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0076-6879(94)44008-5","volume":"244","author":"LB Schwartz","year":"1994","unstructured":"Schwartz LB. Tryptase: a mast cell serine protease. Methods Enzymol. 1994;244:88\u2013100. https:\/\/doi.org\/10.1016\/0076-6879(94)44008-5.","journal-title":"Methods Enzymol"},{"issue":"6","key":"1010_CR41","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.jaci.2006.02.026","volume":"117","author":"GH Caughey","year":"2006","unstructured":"Caughey GH. Tryptase genetics and anaphylaxis. J Allergy Clin Immunol. 2006;117(6):1411\u20134. https:\/\/doi.org\/10.1016\/j.jaci.2006.02.026.","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"1010_CR42","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1084\/jem.20190701","volume":"216","author":"QT Le","year":"2019","unstructured":"Le QT, Lyons JJ, Naranjo AN, Olivera A, Lazarus RA, Metcalfe DD, et al. Impact of naturally forming human alpha\/beta-tryptase heterotetramers in the pathogenesis of hereditary alpha-tryptasemia. J Exp Med. 2019;216(10):2348\u201361. https:\/\/doi.org\/10.1084\/jem.20190701First study to demonstrate the natural and spontaneous formation of \u03b1\/\u03b2-tryptase heterotetramers as well as their unique attributes and substrate selectivity.","journal-title":"J Exp Med"},{"issue":"7","key":"1010_CR43","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1056\/NEJMoa1500611","volume":"374","author":"SE Boyden","year":"2016","unstructured":"Boyden SE, Desai A, Cruse G, Young ML, Bolan HC, Scott LM, et al. Vibratory urticaria associated with a missense variant in ADGRE2. N Engl J Med. 2016;374(7):656\u201363. https:\/\/doi.org\/10.1056\/NEJMoa1500611.","journal-title":"N Engl J Med"},{"issue":"6","key":"1010_CR44","doi-asserted-by":"publisher","first-page":"808","DOI":"10.3349\/ymj.2010.51.6.808","volume":"51","author":"SE Lee","year":"2010","unstructured":"Lee SE, Jeong SK, Lee SH. Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis. Yonsei Med J. 2010;51(6):808\u201322. https:\/\/doi.org\/10.3349\/ymj.2010.51.6.808.","journal-title":"Yonsei Med J"},{"issue":"50","key":"1010_CR45","doi-asserted-by":"publisher","first-page":"33224","DOI":"10.1074\/jbc.273.50.33224","volume":"273","author":"A Kozik","year":"1998","unstructured":"Kozik A, Moore RB, Potempa J, Imamura T, Rapala-Kozik M, Travis J. A novel mechanism for bradykinin production at inflammatory sites. Diverse effects of a mixture of neutrophil elastase and mast cell tryptase versus tissue and plasma kallikreins on native and oxidized kininogens. J Biol Chem. 1998;273(50):33224\u20139. https:\/\/doi.org\/10.1074\/jbc.273.50.33224.","journal-title":"J Biol Chem"},{"issue":"5","key":"1010_CR46","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.4049\/jimmunol.130.5.2352","volume":"130","author":"M Maier","year":"1983","unstructured":"Maier M, Spragg J, Schwartz LB. Inactivation of human high molecular weight kininogen by human mast cell tryptase. J Immunol. 1983;130(5):2352\u20136.","journal-title":"J Immunol"},{"issue":"Pt A","key":"1010_CR47","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-4684-5143-6_15","volume":"198","author":"LB Schwartz","year":"1986","unstructured":"Schwartz LB, Maier M, Spragg J. Interaction of human low molecular weight kininogen with human mast cell tryptase. Adv Exp Med Biol. 1986;198(Pt A):105\u201311. https:\/\/doi.org\/10.1007\/978-1-4684-5143-6_15.","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"1010_CR48","doi-asserted-by":"publisher","first-page":"6307","DOI":"10.4049\/jimmunol.180.9.6307","volume":"180","author":"Y Fukuoka","year":"2008","unstructured":"Fukuoka Y, Xia HZ, Sanchez-Munoz LB, Dellinger AL, Escribano L, Schwartz LB. Generation of anaphylatoxins by human beta-tryptase from C3, C4, and C5. J Immunol. 2008;180(9):6307\u201316. https:\/\/doi.org\/10.4049\/jimmunol.180.9.6307.","journal-title":"J Immunol"},{"issue":"2","key":"1010_CR49","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cell.2019.09.009","volume":"179","author":"HR Maun","year":"2019","unstructured":"Maun HR, Jackman JK, Choy DF, Loyet KM, Staton TL, Jia G, et al. An allosteric anti-tryptase antibody for the treatment of mast cell-mediated severe asthma. Cell. 2019;179(2):417\u201331 e19. https:\/\/doi.org\/10.1016\/j.cell.2019.09.009First study to demonstrate an importance of human tryptase on mast cell histamine release and anaphylaxis severity in a humanized mouse model and successful in vivo prevention of IgE-mediated anaphylaxis in this model by inhibiting tryptase activity.","journal-title":"Cell."},{"issue":"9","key":"1010_CR50","doi-asserted-by":"publisher","first-page":"6072","DOI":"10.4049\/jimmunol.179.9.6072","volume":"179","author":"NN Trivedi","year":"2007","unstructured":"Trivedi NN, Tong Q, Raman K, Bhagwandin VJ, Caughey GH. Mast cell alpha and beta tryptases changed rapidly during primate speciation and evolved from gamma-like transmembrane peptidases in ancestral vertebrates. J Immunol. 2007;179(9):6072\u20139. https:\/\/doi.org\/10.4049\/jimmunol.179.9.6072.","journal-title":"J Immunol"},{"issue":"10","key":"1010_CR51","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1016\/j.jaip.2020.05.057","volume":"8","author":"RC Robey","year":"2020","unstructured":"Robey RC, Wilcock A, Bonin H, Beaman G, Myers B, Grattan C, et al. Hereditary alpha-tryptasemia: UK prevalence and variability in disease expression. J Allergy Clin Immunol Pract. 2020;8(10):3549\u201356. https:\/\/doi.org\/10.1016\/j.jaip.2020.05.057.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"1010_CR52","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.jaip.2019.02.002","volume":"7","author":"M Castells","year":"2019","unstructured":"Castells M, Butterfield J. Mast cell activation syndrome and mastocytosis: initial treatment options and long-term management. J Allergy Clin Immunol Pract. 2019;7(4):1097\u2013106. https:\/\/doi.org\/10.1016\/j.jaip.2019.02.002.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"1010_CR53","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.jaip.2017.11.025","volume":"6","author":"P Bonadonna","year":"2018","unstructured":"Bonadonna P, Zanotti R, Pagani M, Bonifacio M, Scaffidi L, Olivieri E, et al. Anaphylactic reactions after discontinuation of hymenoptera venom immunotherapy: a clonal mast cell disorder should be suspected. J Allergy Clin Immunol Pract. 2018;6(4):1368\u201372. https:\/\/doi.org\/10.1016\/j.jaip.2017.11.025.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"1010_CR54","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.anai.2019.09.026","volume":"124","author":"LB Mendoza Alvarez","year":"2020","unstructured":"Mendoza Alvarez LB, Barker R, Nelson C, DiMaggio T, Stone KD, Milner JD, et al. Clinical response to omalizumab in patients with hereditary alpha-tryptasemia. Ann Allergy Asthma Immunol. 2020;124(1):99\u2013100 e1. https:\/\/doi.org\/10.1016\/j.anai.2019.09.026.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"1010_CR55","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000501637","volume":"180","author":"BA Youngblood","year":"2019","unstructured":"Youngblood BA, Brock EC, Leung J, Falahati R, Bryce PJ, Bright J, et al. AK002, a humanized sialic acid-binding immunoglobulin-like lectin-8 antibody that induces antibody-dependent cell-mediated cytotoxicity against human eosinophils and inhibits mast cell-mediated anaphylaxis in mice. Int Arch Allergy Immunol. 2019;180(2):91\u2013102. https:\/\/doi.org\/10.1159\/000501637Demonstrated in vivo success inhibiting mast cell activation by targeting the inhibitor receptor Siglec-8.","journal-title":"Int Arch Allergy Immunol"},{"key":"1010_CR56","doi-asserted-by":"publisher","unstructured":"Chinthrajah S, Cao S, Liu C, Lyu SC, Sindher SB, Long A, et al. Phase 2a randomized, placebo-controlled study of anti-IL-33 in peanut allergy. JCI Insight. 2019;4(22). https:\/\/doi.org\/10.1172\/jci.insight.131347.","DOI":"10.1172\/jci.insight.131347"},{"issue":"4","key":"1010_CR57","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.iac.2020.06.007","volume":"40","author":"JJ Lyons","year":"2020","unstructured":"Lyons JJ, Metcalfe DD. Targeting mast cells with biologics. Immunol Allergy Clin N Am. 2020;40(4):667\u201385. https:\/\/doi.org\/10.1016\/j.iac.2020.06.007.","journal-title":"Immunol Allergy Clin N Am"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-021-01010-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-021-01010-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-021-01010-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T14:22:19Z","timestamp":1699021339000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-021-01010-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1010"],"URL":"https:\/\/doi.org\/10.1007\/s11882-021-01010-1","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"10 May 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"The authors declare no conflicts of interest relevant to this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"33"}}